EUVIMEDEUVIMED entdecken
Crossref

A Modular Synthetic Approach toward N-Aryl-1,3,4-oxadiazol-2(3H)-one Pharmacophores via Chan–Lam Coupling

Rupali Shivachalappa Salgar, Alagesan Balasubramani, Srihari Pabbaraja, Saumitra Sengupta

Synlett · 01.09.2026 · 37 (14) · 1433-1436

DOI: 10.1055/a-2858-8400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synlett, erschienen am 01.09.2026. Verfasst von Rupali Shivachalappa Salgar und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Department of Science and Technology, New Delhi.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report a modular and efficient synthesis of N-aryl-1,3,4-oxadiazol-2(3H)-one pharmacophores via Chan–Lam coupling of oxadiazolones with (hetero)arylboronic acids. This novel protocol employs readily accessible starting materials under mild, operationally simple conditions, along with wide substrate scope, rendering it a practical and versatile approach for the construction of diverse pharmaceutically relevant N-aryl-1,3,4-oxadiazol-2(3H)-one derivatives.

Förderung

  • Department of Science and Technology, New Delhi

Zitieren

APA

Salgar, R. S., Balasubramani, A., Pabbaraja, S., & Sengupta, S. (2026). A Modular Synthetic Approach toward N-Aryl-1,3,4-oxadiazol-2(3H)-one Pharmacophores via Chan–Lam Coupling. Synlett, 37(14), 1433-1436. https://doi.org/10.1055/a-2858-8400

Vancouver

Salgar RS, Balasubramani A, Pabbaraja S, Sengupta S. A Modular Synthetic Approach toward N-Aryl-1,3,4-oxadiazol-2(3H)-one Pharmacophores via Chan–Lam Coupling. Synlett. 2026;37(14):1433-1436. doi:10.1055/a-2858-8400

BibTeX
@article{Salgar2026,
  author = {Salgar, Rupali Shivachalappa and Balasubramani, Alagesan and Pabbaraja, Srihari and Sengupta, Saumitra},
  title = {A Modular Synthetic Approach toward N-Aryl-1,3,4-oxadiazol-2(3H)-one Pharmacophores via Chan–Lam Coupling},
  journal = {Synlett},
  year = {2026},
  volume = {37},
  number = {14},
  pages = {1433--1436},
  doi = {10.1055/a-2858-8400}
}
Kostenlos starten →